Cablivi (Caplacizumab Vials) 10mg

Cablivi (caplacizumab) is a prescription medication used to treat adults with acquired thrombotic thrombocytopenic purpura (aTTP). This 10mg vial formulation helps manage blood clotting disorders by targeting von Willebrand factor. Suitable for refrigerated storage between 2-8°C.

Strength

10mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Sanofi-Aventis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Caplacizumab is used to treat acquired thrombotic thrombocytopenic purpura (aTTP), a rare blood clotting disorder. It works by reducing the formation of blood clots in the small blood vessels. This medication is typically used alongside plasma exchange and immunosuppressive therapy. What is caplacizumab used for? It helps manage episodes of aTTP in adult patients.

Side Effects

Caplacizumab may help reduce the need for daily plasma exchange in patients with aTTP. Users may experience fewer severe clotting events during treatment. Some patients report improved platelet counts and reduced symptoms over time. Effects vary by individual response.

Precautions & Warnings

Store caplacizumab vials refrigerated between 2-8°C and protect from light. Do not freeze. Handle vials carefully to avoid contamination. Keep out of reach of children. Discard any unused medication properly after the prescribed treatment period.

Avoid Interactions

Caplacizumab may interact with blood thinners or medications affecting platelet function. Caution is advised when combining with other drugs that influence blood clotting. Always inform healthcare providers about all medications being taken. No specific dietary restrictions are required during treatment.

Frequently Asked Questions

Caplacizumab is used to treat acquired thrombotic thrombocytopenic purpura (aTTP) in adults.

It is given as an injection under the skin, typically in a clinical setting.

Common effects may include bleeding or bruising at the injection site.

No, it must be refrigerated between 2-8°C and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.